...
首页> 外文期刊>European journal of neurology: the official journal of the European Federation of Neurological Societies >Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke Scale score during 1-h recombinant tissue-type plasminogen activator infusion
【24h】

Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke Scale score during 1-h recombinant tissue-type plasminogen activator infusion

机译:基于国家健康卒中规模分数的中风成果简单的临床预测因子1-H重组组织型纤溶酶原激活剂输注

获取原文
获取原文并翻译 | 示例
           

摘要

Background and purpose: An index for predictors of stroke outcome was determined based on the National Institutes of Health Stroke Scale (NIHSS) scores during 1-h intravenous administration of recombinant tissue-type plasminogen activator (rt-PA). Methods: Stroke patients with baseline NIHSS score ≥8 and occlusion at the internal carotid or middle cerebral arteries (ICA, MCA) were retrospectively studied from a prospective single-center registry. NIHSS scores and inverse change from baseline scores (ΔNIHSS) were assessed at 30 min and 1 h after rt-PA infusion. Patients were divided into two groups according to arterial occlusion sites: group P, ICA or proximal M1; and group D, distal M1 or M2. A modified Rankin Scale score of 2-6 at 3 months was defined as an unfavorable outcome. Results: In all 108 patients, the cutoff NIHSS score predicting unfavorable outcome was ≥12 and cutoff ΔNIHSS scores were ≤2 at both 30 min and 1 h. In group P (n = 36), the cutoff NIHSS score was ≥14 at both 30 min and 1 h and cutoff ΔNIHSS scores were ≤1 at 30 min and ≤2 at 1 h. Unfavorable outcome was seen in all patients with NIHSS1 h ≥ 14, ΔNIHSS30 min ≤ 1 and ΔNIHSS1 h ≤ 2. In group D (n = 72), the cutoff NIHSS scores were ≥12 at both 30 min and 1 h, and cutoff ΔNIHSS scores were ≤2 at 30 min and ≤7 at 1 h; 90% of patients with unfavorable outcome showed ΔNIHSS1 h ≤ 7. Conclusion: NIHSS and ΔNIHSS during 1-h rt-PA infusion seemed predictive of 3-month outcome when the site of arterial occlusion was identified prior to rt-PA.
机译:背景和目的:基于在1-H静脉施用重组组织型纤溶酶原激活剂(RT-PA)的1-H静脉施用期间,基于国家健康卒中量表(NIHSS)评分确定了卒中结果的预测指标。方法:从一个预期单中心登记次,回顾性地研究了患有基线NIHSS≥8分和闭塞的脑卒中患者,并在内部颈动脉(ICA,MCA)中闭塞。在RT-PA输注后30分钟和1小时评估基线评分(ΔniHS)的分数和逆变化。患者根据动脉闭塞位点分为两组:P组,ICA或近端M1;和D组,远端M1或M2。 3个月的修改Rankin Scale得分为2-6分为不利的结果。结果:在所有108名患者中,预测不利结果的截止NIHSS评分≥12,并且在30分钟和1小时内切断ΔniHSSss≤2。在P组(n = 36)中,截止NIHSS得分≥14在30分钟内≥14,并且在1小时内截止ΔniHSs得分≤1≤2在1小时。在NIHSS1H≥14的所有患者中可以看到不利的结果,ΔniHS30分钟≤1和Δ1h≤2.在D组(n = 72)中,在30分钟和1小时内,截止NIHSS分数≥12,并截止ΔniHSS分数在30分钟后≤2,≤7位为1小时; 90%的患者的不利结果显示ΔniHS1h≤7.结论:在RT-PA之前鉴定出动脉闭塞的部位时,NIHSS和ΔniHS在1-H RT-PA输注期间似乎预测到了3个月的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号